SENNA PLUS- docusate sodium 50 mg and sennosides 8.6 mg tablet, film coated 
CARDINAL HEALTH, 110 DBA LEADER

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Active Ingredients (in each tablet)

Docusate Sodium 50 mg

Sennosides 8.6 mg

Purpose

Stool Softener

Laxative

Uses

Warnings

Do not use

  • if you are taking mineral oil, unless directed by a doctor
  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after the use of a laxative.

These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health professional before use. 

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

                  age

starting dosage

maximum dosage

adults and children 12 years and over

2 tablets once a day 

 4 tablets twice a day

children 6 to under 12 years

1 tablet once a day

 2 tablets twice a day

children 2 to under 6 years 

1/2 tablet once a day

 1 tablet twice a day

children under 2 years

ask a doctor

 ask a doctor

Other information

Inactive ingredients

croscarmellose sodium, D&C Yellow# 10, dicalcium phosphate, FD&C Yellow #6, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium benzoate, talc, titanium dioxide

Questions or comments?

(866) 562-2756 (Mon-Fri 8 AM to 4 PM EST)

LEADER TM

NDC 70000-0520-1

Senna Plus

Docusate Sodium, 50 mg

Sennosides, 8.6 mg

Stool Softener l Laxative

Dual Action

Standardized

Senna Concentrate

COMPARE TO

SENOKOT-S® 

active ingredients*

100% Money

Back Guarantee

30 TABLETS

Leader Senna Plus Tablet 30 ct. Product Label

SENNA PLUS 
docusate sodium 50 mg and sennosides 8.6 mg tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70000-0520
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
Colororange (ORANGE COLOR) Scoreno score
ShapeROUND (ROUND TABLET) Size10mm
FlavorImprint Code PH32
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70000-0520-130 in 1 CARTON10/23/2019
130 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33410/23/2019
Labeler - CARDINAL HEALTH, 110 DBA LEADER (063997360)
Registrant - Pharbest Pharmaceuticals, Inc. (557054835)
Establishment
NameAddressID/FEIBusiness Operations
Pharbest Pharmaceuticals, Inc.557054835manufacture(70000-0520) , analysis(70000-0520) , pack(70000-0520) , label(70000-0520)

Revised: 6/2021
Document Id: cc53f049-bcf4-4d17-b5b1-47b6061f618a
Set id: 4d4101ca-7d78-4712-9b3d-f395f2646c6b
Version: 2
Effective Time: 20210629
 
CARDINAL HEALTH, 110 DBA LEADER